Difference between revisions of "Team:NTNU Trondheim/Description"
| Line 23: | Line 23: | ||
href="https://2017.igem.org/Template:NTNU_Trondheim/CSS/fix_code?action=raw&ctype=text/css" /> | href="https://2017.igem.org/Template:NTNU_Trondheim/CSS/fix_code?action=raw&ctype=text/css" /> | ||
| − | <script src=" | + | <script src="http://code.jquery.com/jquery-latest.min.js" type="text/javascript"></script> |
<script type="text/javascript" src="https://2017.igem.org/Template:NTNU_Trondheim/JS/picture_field_resize?action=raw&ctype=text/javascript"></script> | <script type="text/javascript" src="https://2017.igem.org/Template:NTNU_Trondheim/JS/picture_field_resize?action=raw&ctype=text/javascript"></script> | ||
| Line 123: | Line 123: | ||
<div id="picture_field"> | <div id="picture_field"> | ||
<div id="triangle_topright"> | <div id="triangle_topright"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/e/e6/T--NTNU_Trondheim--top_right_triangle.svg"> |
</div> | </div> | ||
<div id="icon"> | <div id="icon"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/8/89/T--NTNU_Trondheim--logo_wo_background.svg"> |
</div> | </div> | ||
<div id="triangle_topleft"> | <div id="triangle_topleft"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/7/74/T--NTNU_Trondheim--top_left_triangle.svg"> |
</div> | </div> | ||
<div id="slideshow_container"> | <div id="slideshow_container"> | ||
| Line 135: | Line 135: | ||
back the slideshow.js script in the head section--> | back the slideshow.js script in the head section--> | ||
<!-- dimensions 2:1 must be honored for ALL pictures added to slideshow --> | <!-- dimensions 2:1 must be honored for ALL pictures added to slideshow --> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/e/e2/T--NTNU_Trondheim--IMG_8974.jpg"> |
</div> | </div> | ||
</div> | </div> | ||
| Line 141: | Line 141: | ||
<div class="content"> | <div class="content"> | ||
<div class="break_header"> | <div class="break_header"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/4/49/T--NTNU_Trondheim--splitter_header.svg"> |
</div> | </div> | ||
| Line 147: | Line 147: | ||
<h1>Why phages?</h1> | <h1>Why phages?</h1> | ||
<div> | <div> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/5/5c/T--NTNU_Trondheim--fag.png"> |
</div> | </div> | ||
<p> | <p> | ||
| Line 164: | Line 164: | ||
<div class="break_2"> | <div class="break_2"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/5/52/T--NTNU_Trondheim--splitter_2.svg"> |
</div> | </div> | ||
| Line 170: | Line 170: | ||
<h1>Why not yet?</h1> <!-- Don't work properly --> | <h1>Why not yet?</h1> <!-- Don't work properly --> | ||
<div class="image" style="width: 30%;margin-top: -3em"> | <div class="image" style="width: 30%;margin-top: -3em"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/b/bc/T--NTNU_Trondheim--phage_specifficity.png"> |
</div> | </div> | ||
<p> | <p> | ||
| Line 185: | Line 185: | ||
<div class="break_1"> | <div class="break_1"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/6/6d/T--NTNU_Trondheim--splitter_1.svg"> |
</div> | </div> | ||
| Line 191: | Line 191: | ||
<!-- The width of the page the picture will occupy. The height is calculated from it to honor the source dimensions. Should NOT exceed 70%--> | <!-- The width of the page the picture will occupy. The height is calculated from it to honor the source dimensions. Should NOT exceed 70%--> | ||
<!-- margin-top and margin-bottom should be set to reach a suitable amount of whitespace, depending on the image location. 0 by default --> | <!-- margin-top and margin-bottom should be set to reach a suitable amount of whitespace, depending on the image location. 0 by default --> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/3/36/T--NTNU_Trondheim--phage_evolution.png"> |
</div> | </div> | ||
| Line 211: | Line 211: | ||
<div class="footer"> | <div class="footer"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/7/7c/T--NTNU_Trondheim--splitter_footer.svg"> |
<div class="footer_content"> | <div class="footer_content"> | ||
<div class="sponsors"> | <div class="sponsors"> | ||
| − | <a href=" | + | <a href="http://digitallifenorway.org/gb/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/d/da/T--NTNU_Trondheim--SDL_LOGO_ENG_confirmed_version2.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://aquagen.no/en/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/2/27/T--NTNU_Trondheim--AquaGen_forslag1_transparent.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://www.biokjemisk.no/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/f/f4/T--NTNU_Trondheim--NBS_forslag1_transparent.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://www.ntnu.edu/ibt" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/8/83/T--NTNU_Trondheim--Instituttlogo_english_white.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://www.vectronbiosolutions.com/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/8/86/T--NTNU_Trondheim--Vectron_forslag1_transparent.png"> |
</a> | </a> | ||
</div> | </div> | ||
<div class="sosial_media"> | <div class="sosial_media"> | ||
<a href="mailto:igem-team@ntnu.no" > | <a href="mailto:igem-team@ntnu.no" > | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/5/5a/T--NTNU_Trondheim--mail.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://www.facebook.com/igemntnu2017/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/8/8b/T--NTNU_Trondheim--facebook.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://twitter.com/ntnuigem?lang=en/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/8/8b/T--NTNU_Trondheim--twitter.png"> |
</a> | </a> | ||
| − | <a href=" | + | <a href="http://www.instagram.com/ntnu_igem/" target="_blank"> |
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2017/6/64/T--NTNU_Trondheim--instagram.png"> |
</a> | </a> | ||
<p> | <p> | ||
Revision as of 15:56, 30 June 2017
<!DOCTYPE html>
Why phages?
Antibiotic resistance is poised to become one of the greatest dangers of our time. Ever since the discovery of penicillin in 1928, antibiotics have been our first line of defense against bacterial infections. However, widespread overuse of antibiotics, coupled with minimal investment in new treatments have allowed pathogenic bacteria to develop resistances to many antibiotics. Fortunately, there is more than one way to kill bacteria. Bacteriophages (phages for short) are bacteria-specific viruses capable of killing select bacteria while leaving animal cells unharmed. For this reason, phages could potentially synergize with, or even replace antibiotics. This type of treatment is called phage therapy.
Why not yet?
Phage therapy does however have several issues to be ironed out before becoming a mainstream medical treatment. One major stumbling block for phage therapy is the high host specificity of phages. Many phages can only infect certain strains of a bacterial species. This creates the need for either large libraries of potential phages, or a quick method of developing a phage capable of fighting a given bacterial infection. In order to solve this problem, our project attempts the latter method.
Our project
For our project, we aim to develop a method of evolving phages capable of infecting a target bacteria strain. We plan to first harvest a catalogue of phages and identify their host bacteria. Phages are plentiful in nature, and by taking different water and soil samples, we will collect a variety of phages capable of infecting different bacteria. By genetically modifying host bacteria, we will accelerate the natural mutation rate of our respective phages. We plan to set up a controlled environment that favorizes phages capable of also infecting the target bacteria. We believe this method will be capable of quickly producing tailored phages, keeping us one step ahead of the resistant bacteria.
Email: igem-team@ntnu.no
